TITLE

Evaluation and Optimization of Blood Micro-Sampling Methods: Serial Sampling in a Cross-Over Design from an Individual Mouse

AUTHOR(S)
Patel, Nita J.; Wickremsinhe, Enaksha; Yu-hua Hui; Barr, Alexander; Masterson, Nicholas; Ruterbories, Kenneth; Weller, Jennifer; Hanes, Jennifer; Kern, Tom; Perkins, Everett
PUB. DATE
August 2016
SOURCE
Journal of Pharmacy & Pharmaceutical Sciences;2016, Vol. 19 Issue 4, p496
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
120495525

 

Related Articles

  • BIOEQUIVALENCE EVALUATION OF NORFLOXACIN TABLETS BASED ON IN VITRO -- IN VIVO CORRELATION. KHILJEE, SONIA; AHMAD, MAHMOOD; MURTAZA, GHULAM; MADNI, ASADULLAH; AKHTAR, NAVEED; AKHTAR, MUHAMMAD // Pakistan Journal of Pharmaceutical Sciences;Oct2011, Vol. 24 Issue 4, p421 

    Present study was designed to establish in-vitro and in-vivo correlation (IVIVC) of two immediate release tablet formulations of 400mg Norfloxacin [Drug A as test and Drug B as reference]. Dissolution study was conducted in 0.1 N HCI using USP apparatus II. In-vivo evaluation was carried out in...

  • Modified PAXgeneâ„¢ method allows for isolation of high-integrity total RNA from microlitre volumes of mouse whole blood. Krawiec, J. A.; Chen, H.; Alom-Ruiz, S.; Jaye, M. // Laboratory Animals;Oct2009, Vol. 43 Issue 4, p394 

    Analysis of gene expression is often used to evaluate the effects of experimental manipulations in laboratory animals. Blood is a rich source of potential biomarkers, including gene expression information, which may be obtained from whole blood. When compared with the end of a study, when whole...

  • Development of a Highly Sensitive Loop-Mediated Isothermal Amplification (LAMP) Method for the Detection of Loa loa. Fernández-Soto, Pedro; Mvoulouga, Prosper Obolo; Akue, Jean Paul; Abán, Julio López; Santiago, Belén Vicente; Sánchez, Miguel Cordero; Muro, Antonio // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    The filarial parasite Loa loa, the causative agent of loiasis, is endemic in Central and Western Africa infecting 3–13 million people. L. loa has been associated with fatal encephalopathic reactions in high Loa-infected individuals receiving ivermectin during mass drug administration...

  • One Mouse, One Pharmacokinetic Profile: Quantitative Whole Blood Serial Sampling for Biotherapeutics. Joyce, Alison; Wang, Mengmeng; Lawrence-Henderson, Rosemary; Filliettaz, Cynthia; Leung, Sheldon; Xu, Xin; O'Hara, Denise // Pharmaceutical Research;Jul2014, Vol. 31 Issue 7, p1823 

    Purpose: The purpose of this study was to validate the approach of serial sampling from one mouse through ligand binding assay (LBA) quantification of dosed biotherapeutic in diluted whole blood to derive a pharmacokinetic (PK) profile. Methods: This investigation compared PK parameters obtained...

  • A robust design for identification of the Parasite Clearance Estimator. Jamsen, Kris M.; Duffull, Stephen B.; Tarning, Joel; Price, Ric N.; Simpson, Julie A. // Malaria Journal;2013, Vol. 12 Issue 1, p1 

    Background Anti-malarial efficacy needs to be monitored continually to ensure optimal dosing in the face of emerging anti-malarial drug resistance. The efficacy of artemisinin based combination therapies (ACT) is assessed by repeated measurements of parasite density in the blood of patients...

  • Establishing Bioequivalence in Serial Sacrifice Designs. Martin Wolfsegger // Journal of Pharmacokinetics & Pharmacodynamics;Feb2007, Vol. 34 Issue 1, p103 

    Nonclinical in vivo animal studies have to be completed before starting clinical studies of the pharmacokinetic behavior of a drug in human subjects. The classic complete data design, where each animal is sampled for analysis once per time point, is usually only applicable for large animals...

  • The Method Quality of Cross-Over Studies Involved in Cochrane Systematic Reviews. Ding, Hong; Hu, Guang Li; Zheng, Xue Yan; Chen, Qing; Threapleton, Diane Erin; Zhou, Zeng Huan // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Background: It is possible that cross-over studies included in current systematic reviews are being inadequately assessed, because the current risk of bias tools do not consider possible biases specific to cross-over design. We performed this study to evaluate whether this was being done in...

  • OPTIMAL DESIGN AND MATHEMATICAL MODEL APPLIED TO ESTABLISH BIOASSAY PROGRAMS. Sánchez, G.; Rodriguez-Diaz, J. M. // Radiation Protection Dosimetry;2007, Vol. 123 Issue 4, p457 

    Bioassays can be used to estimate the initial intake I for the case of an acute intake exposure for an individual worker. To evaluate the effective dose, apart from I, we need to know other parameters such as activity median aerodynamic diameter (AMAD) or the fraction absorption (f1) in the...

  • A Bioequivalence Study Comparing Two Formulation of Emtricitabine Capsules. Bapuji, A. T.; Nagesh, M.; Ramaraju, D.; Syedba, Syed; Kiran, Ravi; Ravinder, S.; Chandrapal reddy, D. // Journal of Bioequivalence & Bioavailability;2010, Vol. 2 Issue 1, p11 

    This investigation was carried out to evaluate the bioavailability of emtricitabine 200mg capsules (Test) of Aurobindo Pharma Ltd, India, relative to reference product, Emtriva 200mg capsules, manufactured by Gilead Sciences, Inc., USA. The bioavailability study was carried out on 36 healthy...

  • Protocol for assessing the hypotensive effect of evening administration of acetylsalicylic acid: study protocol for a randomized, cross-over controlled trial. Victoria Ruíz-Arzalluz, M.; Cruz Gómez Fernández, M.; Burgos-Alonso, Natalia; Vinyoles, Ernest; Vicente Blanco, Ricardo San; Grandes, Gonzalo // Trials;2013, Vol. 14 Issue 1, p1 

    Background: The objective of this study is to evaluate the antihypertensive effect of bedtime administration of low doses of aspirin in patients with treated hypertension and high cardiovascular risk on low-dose aspirin for secondary prevention, in order to optimize their usual treatment and...

Share

Other Topics